Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KMT2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISY1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
KIF1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYROXD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOL12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NCAPH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBL1X - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSEN54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSD11B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C15orf65 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KAT6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REEP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on